SectorBiological Technology
Established Date--
Listing Date01/08/2016
ExchangeNASDAQ Stock Exchange
Full-time Employees33
Fiscal Year Ends31/12
Security TypeCommon stock
Office address2401 4th Avenue
Suite 1050
Seattle
Washington 98121
Business
IntroductionAptevo Therapeutics Inc., was incorporated in Delaware in February 2016. The company is a clinical-stage R&D biotechnology company focused on developing novel immunotherapy candidates for the treatment of different forms of cancer. The company has developed two multifunctional platform technologies for the rational design of precision immunomodulatory drugs.
